ÂÜÀòÂÒÂ×

Ole Vahlgren is an accomplished executive with extensive experience in the pharmaceutical and biotechnology industries. Currently serving as Chairman of the Board and Board Member at Blue Cell Therapeutics, Ole Vahlgren also holds the position of Chief Executive Officer at AJ Vaccines, a global leader in vaccine development. Previous leadership roles include President and CEO of Otsuka Pharmaceutical Europe Ltd., where significant advancements were made in the company's European operations, and Global Head of Corporate Business Development & Strategy at Lundbeck, where Ole Vahlgren played a pivotal role in expanding the company's global presence. Educational credentials include an MBA from Copenhagen Business School and a Master’s Degree in Electrical and Electronics Engineering from the Technical University of Denmark.